Landlocked developing countries (LLDCs) vs Mauritius: Proportion of the target population who received the final dose of
Landlocked developing countries (LLDCs)
44.0%
in 2024
Mauritius
92.0%
in 2024
Landlocked developing countries (LLDCs) rank
17th
Mauritius rank
6th
Proportion of the target population who received the final dose of over time
- Landlocked developing countries (LLDCs)
- Mauritius
How they compare
Mauritius currently reports 92.0% against 44.0% in Landlocked developing countries (LLDCs), a difference of 48.0%.
That makes Mauritius's figure about 2.1 times Landlocked developing countries (LLDCs)'s.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Mauritius ahead.
Landlocked developing countries (LLDCs) ranks 17th and Mauritius ranks 6th of 35 groups.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 12.3% | 77.3% | 65.0% | Mauritius |
| 2020s | 28.2% | 54.2% | 26.0% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Landlocked developing countries (LLDCs) or Mauritius?
- Mauritius, at 92.0% against 44.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Landlocked developing countries (LLDCs) and Mauritius?
- 48.0%, with Mauritius ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Mauritius?
- 8 years are reported by both, from 2017 to 2024.
- How do Landlocked developing countries (LLDCs) and Mauritius rank globally for proportion of the target population who received the final dose of?
- Landlocked developing countries (LLDCs) ranks 17th and Mauritius ranks 6th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.